What is the appropriate treatment plan for epistaxis (ICD‑10 code R04.0)?

Treatment Plan for Epistaxis (R04.0)

For acute epistaxis, begin with nasal compression for at least 5 minutes, followed by topical vasoconstrictors (oxymetazoline or phenylephrine) if bleeding persists, then proceed to nasal cautery or packing if initial measures fail. 1

Initial Assessment and First-Line Management

Immediate Home/Office Interventions

• Nasal compression: Have the patient lean forward and pinch the soft part of the nose for a minimum of 5 minutes; if bleeding slows, continue holding for a full 15 minutes 1
• Topical vasoconstrictors: If compression alone fails, blow the nose to clear clots, then spray 2 sprays of oxymetazoline or phenylephrine into the bleeding nostril and continue compression for 5 minutes (may repeat once) 1
• These measures control bleeding in 65-75% of patients presenting for acute care 1, 2

Risk Factor Assessment

Identify factors that may complicate management or indicate need for more aggressive intervention 1:

• Anticoagulation/antiplatelet therapy (present in 61% of epistaxis patients) 3
• Hypertension (39% of cases) 4
• Prior nasal/sinus surgery or trauma 1
• Chronic kidney or liver disease 1
• Personal or family history of bleeding disorders 1

Secondary Interventions for Persistent Bleeding

Examination and Bleeding Site Identification

• Anterior rhinoscopy should be performed first; 95% of epistaxis is anterior 4
• Nasal endoscopy is indicated when: 1
  • Bleeding site cannot be identified on anterior examination
  • Bleeding was unusually difficult to control
  • Recurrent epistaxis without obvious anterior source
  • Unilateral symptoms suggesting foreign body or tumor
  • Endoscopy localizes the bleeding site in 87-93% of cases 1

Treatment Based on Identified Bleeding Site

When an anterior bleeding site is identified, use one or more of the following 1:

• Chemical or electrical cautery: Silver nitrate cauterization has 80% initial success rate and is more effective than other modalities with fewer recurrences (14.5% vs 35.1%) 2, 3

  • Critical caveat: Avoid bilateral simultaneous septal cautery due to risk of septal perforation 1
  • After cautery, avoid nose blowing, strenuous activity, and heavy lifting for at least one week 1

• Topical vasoconstrictors: Oxymetazoline or phenylephrine applied via spray or cotton pledget controls 65-75% of cases 1

• Tranexamic acid: Topical application promotes hemostasis in 78% of patients versus 35% with oxymetazoline alone 2

Nasal Packing for Refractory Cases

If cautery and vasoconstrictors fail, proceed to nasal packing 1, 2:

• Anterior packing options:

  • Inflatable anterior nasal balloon packs (e.g., Rapid-Rhino) reliably control most anterior bleeds 5
  • PVA tampons (Merocel) - 26% recurrence rate 3
  • Absorbable materials (Nasopore) with fewer complications 2
  • Newer hemostatic agents (Surgicel, Floseal, Spongostan) are more effective with fewer complications than traditional materials 2

• Posterior packing: For the 5% with posterior epistaxis, add a Foley catheter nasopharyngeal balloon pack 4, 5

• Packing management 1:

  • Consider prophylactic antibiotics for high-risk patients (though evidence is limited) 1
  • Keep packing moist with nasal saline sprays to reduce crusting 1
  • Strict adherence to follow-up for nonresorbable packing removal is essential 1
  • Patients should avoid straining, lifting >10 pounds, bending over, and exercise 1

Advanced Interventions for Severe/Refractory Epistaxis

Surgical Management

For posterior epistaxis failing nasal packing 6, 7:

• Endoscopic arterial ligation (primarily sphenopalatine artery) is more effective than conventional nasal packing (97% vs 62% success) 2, 6
• Endoscopic cauterization is more effective than ligation alone 2
• Recent literature suggests superiority of early surgery over prolonged nasal packing as definitive treatment 7

Interventional Radiology

• Arterial embolization has 80% success rate with comparable efficacy to surgical methods 2
• Use for patients at high risk for general anesthesia or after surgical failure 6, 7
• Typically reserved after surgery failure, except in specific high-risk surgical candidates 7

Prevention and Follow-Up

Preventive Measures

Educate all patients on 1:

• Nasal moisturization: Nasal saline gel or spray 1-3 times daily 1
• Humidification: Bedside humidifier use 1
• Avoid trauma: Eliminate nose picking and vigorous nose blowing 1
• Lubricating agents: Apply after bleeding cessation to prevent recurrence 1

Mandatory Follow-Up

• Document outcomes within 30 days for patients treated with nonresorbable packing, surgery, or arterial ligation/embolization 1
• Monitor for recurrence (26% overall recurrence rate, highest with nasal clips at 59%) 3
• Rebleeding may occur during healing; patients should reapply compression and vasoconstrictors, then seek care if bleeding persists 1

Special Considerations

Anticoagulated Patients

• Do not discontinue anticoagulation without consulting the prescribing physician, as these medications treat serious conditions 1
• If bleeding is severe, hold additional doses until evaluated, but evaluation should not be delayed 1

When to Seek Emergency Care

Immediate evaluation needed for 1:

• Bleeding uncontrolled by compression and vasoconstrictors after 15 minutes
• Severe or persistent bleeding with weakness or lightheadedness
• Fever >101°F, increasing pain, vision changes, or facial swelling after packing 1